{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:55:03Z","timestamp":1790636103936,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005088","name":"Ohio Cancer Research Associates","doi-asserted-by":"publisher","award":["5020"],"award-info":[{"award-number":["5020"]}],"id":[{"id":"10.13039\/100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nucleotide excision repair (NER) and cell cycle checkpoints impact the ability of the anti-cancer drug cisplatin to inhibit cell proliferation and induce cell death. Genetic studies have shown that both NER and cell cycle progression are impacted by the circadian clock, which has emerged as a novel pharmacological target for the treatment of various disease states. In this study, cultured human cell lines were treated with combinations of cisplatin and the circadian clock modulating compounds KS15 and SR8278, which enhance circadian clock transcriptional output by inhibiting the activities of the cryptochrome and REV-ERB proteins, respectively. Treatment of cells with KS15 and SR8278 protected cells against the anti-proliferative effects of cisplatin and increased the expression of NER factor XPA and cell cycle regulators Wee1 and p21 at the mRNA and protein level. Correlated with these molecular changes, KS15 and SR8278 treatment resulted in fewer unrepaired cisplatin\u2013DNA adducts in genomic DNA and a higher fraction of cells in the G1 phase of the cell cycle. Thus, the use of pharmacological agents targeting the circadian clock could be a novel approach to modulate the responses of normal and cancer cells to cisplatin chemotherapy regimens.<\/jats:p>","DOI":"10.1038\/s41598-021-97603-x","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:06:24Z","timestamp":1631181984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Nadeen","family":"Anabtawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cvammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"97603_CR1","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson, E. R. & Lippard, S. J. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99, 2467\u20132498 (1999).","journal-title":"Chem. Rev."},{"key":"97603_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0079-6603(01)67026-0","volume":"67","author":"SM Cohen","year":"2001","unstructured":"Cohen, S. M. & Lippard, S. J. Cisplatin: From DNA damage to cancer chemotherapy. Prog. Nucleic Acid Res. Mol. Biol. 67, 93\u2013130 (2001).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"97603_CR3","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1021\/bi960453+","volume":"35","author":"DB Zamble","year":"1996","unstructured":"Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A. & Lippard, S. J. Repair of cisplatin\u2013DNA adducts by the mammalian excision nuclease. Biochemistry 35, 10004\u201310013 (1996).","journal-title":"Biochemistry"},{"key":"97603_CR4","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1002\/anie.201601524","volume":"55","author":"A Sancar","year":"2016","unstructured":"Sancar, A. Mechanisms of DNA repair by photolyase and excision nuclease (nobel lecture). Angew. Chem. (Int. Ed. English) 55, 8502\u20138527 (2016).","journal-title":"Angew. Chem. (Int. Ed. English)"},{"key":"97603_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K. & Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39\u201385 (2004).","journal-title":"Annu. Rev. Biochem."},{"key":"97603_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179\u2013204 (2010).","journal-title":"Mol. Cell"},{"key":"97603_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","volume":"35","author":"JA Mohawk","year":"2012","unstructured":"Mohawk, J. A., Green, C. B. & Takahashi, J. S. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 35, 445\u2013462 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"97603_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. 18, 164\u2013179 (2017).","journal-title":"Nat. Rev."},{"key":"97603_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"H Cho","year":"2012","unstructured":"Cho, H. et al. Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature 485, 123\u2013127 (2012).","journal-title":"Nature"},{"key":"97603_CR10","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc. Natl. Acad. Sci. USA 111, 16219\u201316224 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"97603_CR11","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1073\/pnas.0812638106","volume":"106","author":"TH Kang","year":"2009","unstructured":"Kang, T. H., Reardon, J. T., Kemp, M. & Sancar, A. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc. Natl. Acad. Sci. USA 106, 2864\u20132867 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"97603_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1086271","volume":"302","author":"T Matsuo","year":"2003","unstructured":"Matsuo, T. et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255\u2013259 (2003).","journal-title":"Science"},{"key":"97603_CR13","doi-asserted-by":"publisher","first-page":"18790","DOI":"10.1073\/pnas.1115249108","volume":"108","author":"S Gaddameedhi","year":"2011","unstructured":"Gaddameedhi, S., Selby, C. P., Kaufmann, W. K., Smart, R. C. & Sancar, A. Control of skin cancer by the circadian rhythm. Proc. Natl. Acad. Sci. USA 108, 18790\u201318795 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"97603_CR14","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1073\/pnas.0915085107","volume":"107","author":"TH Kang","year":"2010","unstructured":"Kang, T. H., Lindsey-Boltz, L. A., Reardon, J. T. & Sancar, A. Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 107, 4890\u20134895 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"97603_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/jid.2014.508","volume":"135","author":"S Gaddameedhi","year":"2015","unstructured":"Gaddameedhi, S., Selby, C. P., Kemp, M. G., Ye, R. & Sancar, A. The circadian clock controls sunburn apoptosis and erythema in mouse skin. J. Invest. Dermatol. 135, 1119\u20131127 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"97603_CR16","doi-asserted-by":"publisher","first-page":"E4777","DOI":"10.1073\/pnas.1804493115","volume":"115","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues. Proc. Natl. Acad. Sci. USA 115, E4777\u2013E4785 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"97603_CR17","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.18632\/oncotarget.24539","volume":"9","author":"PP Dakup","year":"2018","unstructured":"Dakup, P. P. et al. The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models. Oncotarget 9, 14524\u201314538 (2018).","journal-title":"Oncotarget"},{"key":"97603_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4161\/cc.4.7.1792","volume":"4","author":"MP Antoch","year":"2005","unstructured":"Antoch, M. P., Kondratov, R. V. & Takahashi, J. S. Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle 4, 901\u2013907 (2005).","journal-title":"Cell Cycle"},{"key":"97603_CR19","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.febslet.2010.03.017","volume":"584","author":"A Sancar","year":"2010","unstructured":"Sancar, A. et al. Circadian clock control of the cellular response to DNA damage. FEBS Lett. 584, 2618\u20132625 (2010).","journal-title":"FEBS Lett."},{"key":"97603_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fneur.2017.00100","volume":"8","author":"GF Gloston","year":"2017","unstructured":"Gloston, G. F., Yoo, S. H. & Chen, Z. J. Clock-enhancing small molecules and potential applications in chronic diseases and aging. Front. Neurol. 8, 100 (2017).","journal-title":"Front. Neurol."},{"key":"97603_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-pharmtox-010617-052645","volume":"58","author":"Z Chen","year":"2018","unstructured":"Chen, Z., Yoo, S. H. & Takahashi, J. S. Development and therapeutic potential of small-molecule modulators of circadian systems. Annu. Rev. Pharmacol. Toxicol. 58, 231\u2013252 (2018).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"97603_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbrc.2015.09.103","volume":"467","author":"SK Chun","year":"2015","unstructured":"Chun, S. K. et al. A synthetic cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells. Biochem. Biophys. Res. Commun. 467, 441\u2013446 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"97603_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lfs.2018.03.022","volume":"200","author":"J Jang","year":"2018","unstructured":"Jang, J. et al. The cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Life Sci. 200, 49\u201355 (2018).","journal-title":"Life Sci."},{"key":"97603_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1021\/cb1002575","volume":"6","author":"D Kojetin","year":"2011","unstructured":"Kojetin, D., Wang, Y., Kamenecka, T. M. & Burris, T. P. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem. Biol. 6, 131\u2013134 (2011).","journal-title":"ACS Chem. Biol."},{"key":"97603_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1021\/bi5007354","volume":"54","author":"A Sancar","year":"2015","unstructured":"Sancar, A. et al. Circadian clock, cancer, and chemotherapy. Biochemistry 54, 110\u2013123 (2015).","journal-title":"Biochemistry"},{"key":"97603_CR26","doi-asserted-by":"publisher","first-page":"e3457","DOI":"10.1371\/journal.pone.0003457","volume":"3","author":"C Vollmers","year":"2008","unstructured":"Vollmers, C., Panda, S. & DiTacchio, L. A high-throughput assay for siRNA-based circadian screens in human U2OS cells. PLoS ONE 3, e3457 (2008).","journal-title":"PLoS ONE"},{"key":"97603_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/jid.2010.315","volume":"131","author":"F Sp\u00f6rl","year":"2011","unstructured":"Sp\u00f6rl, F. et al. A circadian clock in HaCaT keratinocytes. J. Invest. Dermatol. 131, 338\u2013348 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"97603_CR28","first-page":"1596","volume":"54","author":"DL Evans","year":"1994","unstructured":"Evans, D. L., Tilby, M. & Dive, C. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res. 54, 1596\u20131603 (1994).","journal-title":"Cancer Res."},{"key":"97603_CR29","doi-asserted-by":"publisher","first-page":"111678","DOI":"10.1016\/j.mrfmmm.2019.111678","volume":"816-818","author":"RJ Hutcherson","year":"2019","unstructured":"Hutcherson, R. J. & Kemp, M. G. ATR kinase inhibition sensitizes quiescent human cells to the lethal effects of cisplatin but increases mutagenesis. Mutat. Res. 816\u2013818, 111678 (2019).","journal-title":"Mutat. Res."},{"key":"97603_CR30","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/nar\/gkq1318","volume":"39","author":"TH Kang","year":"2011","unstructured":"Kang, T. H., Reardon, J. T. & Sancar, A. Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein. Nucleic Acids Res. 39, 3176\u20133187 (2011).","journal-title":"Nucleic Acids Res."},{"key":"97603_CR31","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","volume":"76","author":"WS El-Deiry","year":"2016","unstructured":"El-Deiry, W. S. p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 76, 5189\u20135191 (2016).","journal-title":"Cancer Res."},{"key":"97603_CR32","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1074\/jbc.M705576200","volume":"283","author":"A Gr\u00e9chez-Cassiau","year":"2008","unstructured":"Gr\u00e9chez-Cassiau, A., Rayet, B., Guillaumond, F., Teboul, M. & Delaunay, F. The circadian clock component BMAL1 is a critical regulator of p21WAF1\/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283, 4535\u20134542 (2008).","journal-title":"J. Biol. Chem."},{"key":"97603_CR33","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/cmdc.201500260","volume":"10","author":"JW Lee","year":"2015","unstructured":"Lee, J. W. et al. Development of small-molecule cryptochrome stabilizer derivatives as modulators of the circadian clock. ChemMedChem 10, 1489\u20131497 (2015).","journal-title":"ChemMedChem"},{"key":"97603_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","volume":"485","author":"LA Solt","year":"2012","unstructured":"Solt, L. A. et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485, 62\u201368 (2012).","journal-title":"Nature"},{"key":"97603_CR35","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1158\/2159-8290.CD-19-0215","volume":"9","author":"Z Dong","year":"2019","unstructured":"Dong, Z. et al. Targeting glioblastoma stem cells through disruption of the circadian clock. Cancer Discov. 9, 1556\u20131573 (2019).","journal-title":"Cancer Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97603-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:22:26Z","timestamp":1670080946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97603-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97603-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"25 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17997"}}